Transcribed explores the human stories behind biotech breakthroughs. Benchling CEO Sajith Wickramasekara sits down with scientists, founders, and R&D leaders to talk candidly about the decisions shaping modern biotech. From career pivots to breakthroughs, setbacks, and lessons in leadership, these are real conversations with the people moving science forward.
All content for Transcribed is the property of Benchling and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Transcribed explores the human stories behind biotech breakthroughs. Benchling CEO Sajith Wickramasekara sits down with scientists, founders, and R&D leaders to talk candidly about the decisions shaping modern biotech. From career pivots to breakthroughs, setbacks, and lessons in leadership, these are real conversations with the people moving science forward.
Andrew Bellinger on contrarian bets — and pioneering gene editing at Verve
Transcribed
48 minutes 59 seconds
2 weeks ago
Andrew Bellinger on contrarian bets — and pioneering gene editing at Verve
Andrew Bellinger discusses what it takes to build new drug modalities from scratch, the bold bets and tough calls that shaped Verve’s journey, and lessons in building new companies from first-in-class science.
Transcribed
Transcribed explores the human stories behind biotech breakthroughs. Benchling CEO Sajith Wickramasekara sits down with scientists, founders, and R&D leaders to talk candidly about the decisions shaping modern biotech. From career pivots to breakthroughs, setbacks, and lessons in leadership, these are real conversations with the people moving science forward.
